Implementation and Cost Analysis of a Novel Silicosis Case-Finding Program For Mine Workers in Rural Rwanda.


Journal

Global health, science and practice
ISSN: 2169-575X
Titre abrégé: Glob Health Sci Pract
Pays: United States
ID NLM: 101624414

Informations de publication

Date de publication:
19 Mar 2024
Historique:
received: 08 09 2023
accepted: 27 02 2024
pubmed: 15 3 2024
medline: 15 3 2024
entrez: 14 3 2024
Statut: aheadofprint

Résumé

Little is known about the burden of silicosis in Africa, despite extensive mining and construction operations in the region putting numerous people at risk. The implementation experience and costs of case-finding for occupational lung disease in resource-limited settings are also currently unknown. We describe the first-ever silicosis case-finding project in rural Rwanda using chest X-ray, symptom questionnaires, and spirometry. This was coupled with routine noncommunicable disease case-finding for diabetes and hypertension. We performed an ingredient-based analysis of the costs of all case-finding activities. In 2022, over 25 days, 1,032 mine workers were included in the program, of which 1,014 (98.3%) completed silicosis case-finding activities. The total cost of the program was estimated to be US$38,656, representing a cost of US$37.49 per person. We conclude that conducting large-scale occupational lung disease case-finding is clinically and economically feasible in resource-limited settings and can be effectively integrated with routine noncommunicable disease case-finding.

Identifiants

pubmed: 38485283
pii: GHSP-D-23-00290
doi: 10.9745/GHSP-D-23-00290
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Tumusime et al.

Auteurs

Robert Tumusime (R)

Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.

Michael S Miller (MS)

Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. mmiller2493@gmail.com.

Anne Niyigena (A)

Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.

Symaque Dusabeyezu (S)

Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.

Pierrot Uwitonze (P)

Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.

Emmanuel Harerimana (E)

Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.

Grace Umugiraneza (G)

Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.

Wellars Dusingizimana (W)

Ministry of Health of Rwanda, Kigali, Rwanda.
Rwinkwavu District Hospital, Kayonza, Rwanda.

Samuel Hatfield (S)

Department of Medicine, University of California at San Francisco, San Francisco, CA, USA.

Stella Savarimuthu (S)

Department of Medicine, Yale New Haven Hospital, New Haven, CT, USA.

Juliana Lawrence (J)

Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Pacifique Hagenimana (P)

Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.

Jean Marie Vianney Ngenzi (JMV)

Wolfram Mining and Processing Ltd, Kigali, Rwanda.

Aristarque Murara (A)

Wolfram Mining and Processing Ltd, Kigali, Rwanda.

Phoebe Mwiseneza (P)

Ministry of Health of Rwanda, Kigali, Rwanda.
Rwinkwavu District Hospital, Kayonza, Rwanda.

Paul Sonenthal (P)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Partners In Health, Boston, MA, USA.

Vincent K Cubaka (VK)

Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.

Fredrick Kateera (F)

Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.

Innocent Kamali (I)

Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.

Classifications MeSH